Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC
Clinical trial NCT05203276 · UNKNOWN
Trial details
- NCT number
- NCT05203276
- Sponsor
- The First People's Hospital of Lianyungang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2024-05-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.